Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1), encoded by the Pecam1 gene in mice, is a 130 kDa transmembrane glycoprotein belonging to the immunoglobulin superfamily . It is expressed on endothelial cells, platelets, monocytes, neutrophils, and subsets of lymphocytes, playing critical roles in vascular biology, immune regulation, and cell signaling . Mouse models of PECAM-1 deficiency (Pecam1<sup>−/−</sup>) have been instrumental in elucidating its functions in inflammation, angiogenesis, and disease progression .
The Pecam1 gene (Ensembl ID: ENSMUSG00000020717) produces eight splice variants with diverse protein isoforms :
Transcript ID | Protein Length | Biotype | UniProt ID | Key Features |
---|---|---|---|---|
ENSMUST00000068021.9 | 732 aa | Protein coding | B1ARB3 | Canonical, TSL:2 |
ENSMUST00000106796.9 | 727 aa | Protein coding | Q08481-1 | CCDS79069, TSL:1 |
ENSMUST00000080853.11 | 716 aa | Protein coding | Q08481-3 | CCDS25559, TSL:1 |
ENSMUST00000183610.8 | 626 aa | Protein coding | Q08481-4 | CCDS79068, TSL:1 |
TSL: Transcript Support Level; aa: amino acids .
Structure: Comprises six extracellular Ig-like domains, a transmembrane domain, and a cytoplasmic tail with immunoregulatory tyrosine motifs (ITIM/ITSM) .
Interactions: Mediates homophilic (cell-cell) and heterophilic (e.g., CD38 on NK cells) binding . Phosphorylated tyrosine residues recruit SHP-2, modulating leukocyte activation and vascular signaling .
PECAM-1 facilitates neutrophil and monocyte migration through endothelial junctions. In Pecam1<sup>−/−</sup> mice:
Peritonitis Model: Neutrophils exhibit delayed detachment from vessel walls, impairing migration to inflammatory sites .
Experimental Autoimmune Encephalomyelitis (EAE): Earlier onset of symptoms and enhanced leukocyte infiltration into the CNS .
Atherosclerosis: Pecam1<sup>−/−</sup> Apoe<sup>−/−</sup> mice show reduced lesion formation due to suppressed NF-κB signaling in endothelial cells .
Vascular Permeability: Prolonged endothelial barrier disruption in response to histamine .
B16-F10 Melanoma: Pecam1<sup>−/−</sup> mice exhibit reduced tumor cell proliferation and altered histology in pre-angiogenic lesions .
Mechanism: Loss of PECAM-1 decreases TIMP-1, IL-11, and other pro-metastatic factors in co-culture models .
Observation | Wild-Type vs. Pecam1<sup>−/−</sup> Mice | Citation |
---|---|---|
Tumor cell proliferation (PCNA staining) | 58% vs. 32% in pre-angiogenic nodules | |
Endothelial-derived TIMP-1 levels | 120 pg/mL vs. 45 pg/mL |
MEC7.46 Antibody: Targets endothelial-specific PECAM-1 isoform (130 kDa), used for immunohistochemistry and flow cytometry .
Recombinant Mouse PECAM-1: Utilized in adhesion assays (R&D Systems #3628-PC-050) .
EENSFTINSI HMESLPSWEV MNGQQLTLEC LVDISTTSKS RSQHRVLFYK DDAMVYNVTS REHTESYVIP QARVFHSGKY KCTVMLNNKE KTTIEYEVKV HGVSKPKVTL DKKEVTEGGV VTVNCSLQEE KPPIFFKIEK LEVGTKFVKR RIDKTSNENF VLMEFPIEAQ DHVLVFRCQA GILSGFKLQE SEPIRSEYVT VQESFSTPKF EIKPPGMIIE GDQLHIRCIV QVTHLVQEFT EIIIQKDKAI VATSKQSSEA VYSVMAMVEY SGHYTCKVES NRISKASSIM VNITELFPKP KLEFSSSRLD QGELLDLSCS VSGTPVANFT IQKEETVLSQ YQNFSKIAEE SDSGEYSCTA GIGKVVKRSG LVPIQVCEML SKPSIFHDAK SEIIKGHAIG ISCQSENGTA PITYHLMKAK SDFQTLEVTS NDPATFTDKP TRDMEYQCRA DNCHSHPAVF SEILRVRVIA PVDEVVISIL SSNEVQSGSE MVLRCSVKEG TSPITFQFYK EKEDRPFHQA VVNDTQAFWH NKQASKKQEG QYYCTASNRA SSMRTSPRSS TLAVRVFLAP WKK HHHHH
PECAM1 in mice is a transmembrane glycoprotein with extracellular, transmembrane, and cytoplasmic domains. The mouse PECAM1 protein spans from Glu18 to Lys590, with homology to human PECAM1 . It is predominantly expressed on:
Vascular endothelial cells (particularly concentrated at intercellular junctions)
Platelets
Subsets of leukocytes, including neutrophils, monocytes, and NK cells
Some lymphocyte subpopulations
Expression levels vary by tissue type, with highest expression in highly vascularized tissues. The protein functions as a cell adhesion molecule and participates in cellular signaling pathways critical for vascular integrity and immune cell migration .
PECAM1 knockout mice are generated through several approaches:
Global Knockout Method:
Target the PECAM1 gene (particularly exons 1 and 2) through homologous recombination in embryonic stem cells
Select positive ES cell clones using neomycin resistance
Inject targeted ES cells into C57BL/6 blastocysts
Implant blastocysts into pseudo-pregnant females
Breed chimeric offspring to establish germline transmission
Confirm knockout through PCR genotyping, Western blotting, and immunohistochemistry
Conditional Knockout Method:
Generate a targeting construct containing loxP sites flanking PECAM1 exons 1 and 2
Include a neomycin resistance gene flanked by FRT sites
Electroporate into C57BL/6 embryonic stem cells
Select and validate correctly targeted ES cell clones
Generate chimeric animals by blastocyst injection
Breed with FLP1-expressing mice to remove the neomycin cassette
Cross PECAM1^flox/flox mice with tissue-specific Cre recombinase-expressing mice
Validation typically involves confirming loss of PECAM1 expression through immunostaining, flow cytometry, and Western blot analysis .
PECAM1 knockout mice exhibit several notable phenotypic characteristics:
These mice develop normally but show significant alterations in inflammatory responses and vascular integrity maintenance, indicating PECAM1's critical role in these processes .
PECAM1 deficiency significantly impacts vascular permeability regulation:
Mechanistic Basis:
PECAM1-deficient endothelial cells exhibit prolonged permeability changes in response to histamine treatment compared to PECAM1-reconstituted cells
PECAM1 knockout mice demonstrate exaggerated and prolonged CNS vascular permeability during the development of EAE
There is a delay in restoration of dermal vascular integrity following histamine challenge in PECAM1 knockout mice
Molecular Mechanisms:
PECAM1 stabilizes endothelial junctions through homophilic binding
It participates in signaling pathways that restore barrier function after inflammatory challenges
The protein interacts with cytoskeletal components to maintain junction integrity
PECAM1 modulates VE-cadherin-based adherens junction stability
Experimental Approach for Studying Permeability:
Evans blue extravasation assay to quantify vascular leak
Intravital microscopy to visualize real-time permeability changes
Transwell permeability assays with isolated endothelial cells
Measurement of transendothelial electrical resistance (TEER)
The impaired barrier restoration in PECAM1-deficient models underscores its role as a negative regulator of vascular permeability and importance in maintaining vascular homeostasis .
PECAM1 plays a crucial regulatory role in EAE progression:
Key Findings:
PECAM1-deficient mice exhibit an earlier onset of clinical symptoms during EAE compared to wild-type counterparts
During EAE, mononuclear cell extravasation and CNS infiltration occur at earlier time points in PECAM1-KO mice
The absence of PECAM1 leads to enhanced T lymphocyte transendothelial migration in vitro
Mechanistic Contributions:
PECAM1 regulates the integrity of the blood-brain barrier (BBB) during inflammatory challenges
It modulates the kinetics and extent of immune cell infiltration into the CNS
PECAM1 influences the restoration of vascular integrity after inflammatory insult
Experimental Approaches:
MOG immunization model for chronic EAE induction in C57BL/6 mice
Clinical scoring to assess disease progression
Histopathological examination of CNS tissues for immune cell infiltration
In vitro transendothelial migration assays with T cells across PECAM1-deficient endothelial monolayers
Assessment of BBB permeability using tracer molecules
The EAE model in PECAM1-deficient mice reveals its importance in regulating both immune cell trafficking and vascular integrity in the context of neuroinflammation .
Recent research has uncovered a significant interaction between PECAM1 and PIEZO1:
Interaction Characteristics:
PIEZO1 and PECAM1 physically interact at cell-cell junctions, as demonstrated by FRET analysis
This interaction is mediated by specific C-terminal residues in PECAM1, particularly Y713
The Y713F mutation in PECAM1 prevents FRET signaling with PIEZO1 and reduces PIEZO1 recruitment to junctions
Functional Consequences:
PECAM1 inhibits PIEZO1 mechanical sensitivity, shifting the pressure-response curve to the right
PECAM1 reduces PIEZO1 activity measured as total charge flow per pressure step
This interaction potentially serves as a mechanical sensitivity regulator in endothelial junctions
Experimental Approaches:
Patch-clamp recordings of PIEZO1 channel activity in the presence/absence of PECAM1
FRET analysis using fluorescently tagged PIEZO1 and PECAM1
Site-directed mutagenesis of key residues (Y713F, C622A, S700F)
Pressure-response curve analysis to quantify mechanical sensitivity
Localization studies with tagged proteins to identify junctional enrichment
This interaction represents a novel mechanism by which PECAM1 regulates mechanosensitivity at vascular junctions, with implications for endothelial responses to flow and pressure .
Conditional PECAM1 knockout mice provide sophisticated tools for tissue-specific analysis:
Generation Strategy:
Creation of a targeting construct with loxP sites flanking PECAM1 exons 1 and 2
Incorporation of a neomycin resistance gene flanked by FRT sites positioned upstream of the 3' loxP site
Electroporation into C57BL/6 embryonic stem cells
Injection of correctly targeted ES cells into blastocysts
Breeding chimeric animals with FLP1-expressing mice to remove the neomycin cassette
Conditional Knockout Applications:
Crossing with Sox2Cre mice to generate global knockouts
Crossing with Tie2Cre for endothelial/hematopoietic-specific deletion
Crossing with CD11cCre for dendritic cell-specific deletion
Crossing with LysMCre for myeloid cell-specific deletion
Validation and Characterization:
PCR genotyping to confirm presence of floxed alleles and Cre recombinase
Western blot analysis to verify tissue-specific PECAM1 deletion
Immunofluorescence to visualize cellular-specific deletion patterns
Functional assays to assess tissue-specific consequences
This approach enables researchers to distinguish the roles of PECAM1 in different cell types and overcome the limitations of global knockout models where compensatory mechanisms may mask phenotypes .
PECAM1's role in leukocyte transmigration is highly context-dependent:
Leukocyte Subtype Specificity:
PECAM1 mediates transmigration of monocytes, neutrophils, and NK cells
Only specific subsets of lymphocytes utilize PECAM1 for transmigration
Stimulus Specificity:
Inflammatory Stimulus | PECAM1 Dependency | Tissue/Model |
---|---|---|
IL-1β | Required | Mouse cremaster muscle, lung, rat mesentery |
TNFα | Not required | Mouse cremaster muscle, lung |
HCl, adenovirus | Not required | Mouse lung |
L-NAME, H₂O₂ | Required | Rat mesentery |
FMLP, thrombin | Not required | Rat mesentery |
IL-8, LTB₄ | Not required | In vitro endothelial models |
Mechanistic Contributions:
PECAM1 facilitates migration through the endothelial junction via homophilic interactions
It mediates migration through the basement membrane via PECAM1-integrin interactions
Involvement in intracellular signaling that regulates directional migration
Experimental Approaches:
Intravital microscopy to visualize leukocyte-endothelial interactions
Transwell migration assays with different inflammatory stimuli
Parallel plate flow chamber assays to assess transmigration under flow
Tissue-specific analysis of leukocyte infiltration in inflammatory models
This differential involvement highlights PECAM1 as a context-specific regulator of leukocyte transmigration, dependent on both the leukocyte subtype and the nature of the inflammatory stimulus .
Recombinant mouse PECAM1 proteins provide valuable tools for mechanistic studies:
Available Forms:
Full-length extracellular domain (Glu18-Lys590)
Domain-specific constructs
Experimental Applications:
Binding Studies:
Solid-phase binding assays to identify interaction partners
Surface plasmon resonance to determine binding kinetics
Co-immunoprecipitation experiments with potential binding partners
Functional Assays:
Blocking antibody studies to inhibit specific interactions
Competition assays with soluble PECAM1 versus membrane-bound forms
Reconstitution experiments in PECAM1-deficient systems
Structural Studies:
Crystallography of PECAM1 domains
Cryo-EM for larger complexes
Domain mapping for interaction surfaces
In vivo Administration:
Competitive inhibition of PECAM1-dependent processes
Tracking studies with labeled recombinant protein
Rescue experiments in PECAM1-deficient animals
Quality Control Parameters:
Protein activity measured by binding assays (ED₅₀ of 0.060-0.720 μg/mL)
Purity assessment by SDS-PAGE
Endotoxin testing for in vivo applications
Recombinant PECAM1 proteins serve as essential tools for dissecting molecular mechanisms in both cell culture and in vivo mouse models .
Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1), also known as CD31, is a protein encoded by the PECAM1 gene. It is a member of the immunoglobulin superfamily and is primarily found on the surface of platelets, monocytes, neutrophils, and certain types of T-cells. PECAM-1 plays a crucial role in various physiological processes, including leukocyte migration, angiogenesis, and integrin activation .
PECAM-1 is a 130-kilodalton glycoprotein that consists of six extracellular immunoglobulin-like domains, a transmembrane domain, and a cytoplasmic tail containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs). These ITIMs are essential for recruiting and activating protein-tyrosine phosphatases, such as SHP-1 and SHP-2 .
In mice, PECAM-1 is expressed at the lateral junctions of endothelial cells and on the surface of various hematopoietic cells, including monocytes, neutrophils, natural killer cells, platelets, and naive T and B cells . The expression of PECAM-1 is crucial for maintaining the integrity of endothelial cell junctions and facilitating cell-cell adhesion .
PECAM-1 is involved in several key biological functions:
Leukocyte Transendothelial Migration (TEM): PECAM-1 is required for the efficient migration of leukocytes across endothelial barriers during inflammatory responses. It facilitates the trafficking of leukocytes to and from the lateral border recycling compartment (LBRC), which is essential for TEM .
Angiogenesis: PECAM-1 plays a role in the formation of new blood vessels by promoting endothelial cell-cell adhesion and signaling .
Integrin Activation: PECAM-1 is involved in the activation of integrins, which are essential for cell adhesion and signaling .
Regulation of B-cell Development: PECAM-1 acts as a regulator of B-cell development and activation. PECAM-1-deficient mice exhibit a hyperresponsive B-cell phenotype, increased numbers of B-1 cells, and reduced B-2 cells. These mice also develop autoantibodies and lupus-like autoimmune disease with age .
Negative Regulation of Platelet-Collagen Interactions: PECAM-1 negatively regulates platelet-collagen interactions, which are crucial for platelet adhesion and aggregation during blood clotting .
Recombinant PECAM-1, particularly from mouse sources, is widely used in research to study its functions and interactions. Recombinant proteins are produced using various expression systems, such as bacterial, yeast, insect, or mammalian cells. These proteins are then purified and used in various assays to investigate the role of PECAM-1 in different biological processes.